Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Stimulant Abuse
Total 0 results
Nothing found
Sponsors and Collaborators
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Alma Lasers Inc.
Kupfer, David J., M.D.
Eurofins Genoma
ASST Cremona, Cremona
Korean Society of Spine Surgery
Hospital ASEPEYO Sant Cugat
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Apollo Neuroscience, Inc.
Nacuity Pharmaceuticals, Inc.
Hospital Durand, Argentina
Agency for Science, Technology and Research
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
GFI
Neurophth Therapeutics Inc
Mª Victoria Maestre Sanchez
Aptis Medical
Everett Meyer
RMIT University, Melbourne, Australia
View Full List
Medical Conditions
T-LGL Leukemia
Rheumatoid Arthritis(RA)
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
The Strength Properties of the Aorta in Vitro
RISS Stage III Plasma Cell Myeloma
Disorder of Fluid Balance
Metachronous Adenoma
Scleredema
Chronic Constipation Symptoms
Luteal Phase Support
Treatment Decisions
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Splenic Trauma
Immune-Mediated Inflammatory Disease
Gastric Cancer Stage IIIB-IIIC
Fever
Corneal Cross-Linking
Recurrent Clear Cell Sarcoma of Soft Tissue
Major Liver Surgery
Dienogest
View Full List
Drug Interventions
MLN2480
RDX227675
Anticholinergic
Camptosar
PD-1/PD-L1 inhibitor
Standard of care (SOC) for COVID-19
OnabotulinumtoxinA
Olopatadine
Capecitabine/cisplatin
Intravenous deferiprone
Intravenous Formulation of PD-0332991
GLPG1837 multiple ascending doses
Oxycodone/acetaminophen 5/325 mg
Fospropofol disodium, propofol
Midazolam
Capecitabine and IMRT (if randomized to this arm)
THC
Letrozole
Desvenlafaxine
TPN-101
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Azerbaijan
Contract Research Organizations in China
Contract Research Organizations in Cyprus
Contract Research Organizations in Djibouti
Contract Research Organizations in Estonia
Contract Research Organizations in Germany
Contract Research Organizations in Ireland
Contract Research Organizations in Macedonia
Contract Research Organizations in Malta
Contract Research Organizations in Qatar
Contract Research Organizations in Sweden
Contract Research Organizations in United Arab Emirates
CRO list by country
CROs in Malaysia
Celero
Syneos Health
ClinActis
IQVIA
Novotech
ACROSS Global
Parexel
SGS
Info Kinetics Sdn Bhd
Caidya
All CROs in Malaysia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe